Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06371092
Other study ID # 2023/01
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date January 31, 2023
Est. completion date March 1, 2023

Study information

Verified date April 2024
Source University of Santiago de Compostela
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this study is to evaluate if the use of UltraEZ during at-home bleaching treatment is effective in reducing tooth sensitivity, as well as doesn't affect the degree of tooth bleaching.


Description:

1. Visit 1: Study information and delivery of informed consent. Recording of the patient's medical history, general examination, and prophylaxis. Alginate impressions will be taken of the upper and lower arches for all patients who meet the inclusion criteria. The impressions will be poured into plaster, and individualized bleaching trays will be made for each patient. A positioning guide tray will be fabricated for color measurement. 2. Visit 2: Initial color measurement with a spectrophotometer and the positioning guide. Each patient will receive their individualized trays. Additionally, they will be given 3 syringes of bleaching agent (Opalescence 16%, Ultradent Products) and one syringe of desensitizing agent (UltraEZ, Ultradent Products) or placebo (glycerin), according to their study group. Both the desensitizing agent and placebo will be dispensed in identical syringes, coded as A and B, to ensure the blinding of the study; only the clinician responsible for randomization knows the coding. Each patient will be provided with an instruction sheet and recording sheets to fill out daily during the 3-week study period. They will record the degree of dental sensitivity . 3. Visit 3: First-week bleaching review. Data collection (color + sensitivity). 4. Visit 4: Second-week bleaching review. Data collection (color + sensitivity). 5. Visit 5: Third-week bleaching review and end of the study. Data collection (color + sensitivity).


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date March 1, 2023
Est. primary completion date February 22, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - No oral or systemic pathology - Periodontally healthy - No cavities - Tooth shade of the upper and lower canines A2 or darker Exclusion Criteria: - Adhesive restorations or prostheses in the anterior region - Enamel or dentin alterations - Smoking - Pregnant women - Undergone prior bleaching treatment

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
UltraEZ
General examination with bite-wings. Dental prophylaxis (dental scaling and polishing with an abrasive paste). Alginate impressions of both arches. Creation of individualized bleaching trays and a position-finder tray of both arches. Application of the UltraEZ gel in the bleaching trays for 30 minutes. Application of the bleaching gel in the bleaching trays during 6-8 hours
Placebo
General examination with bite-wings. Dental prophylaxis (dental scaling and polishing with an abrasive paste). Alginate impressions of both arches. Creation of individualized bleaching trays and a position-finder tray of both arches. Application of the placebo gel in the bleaching trays for 30 minutes. Application of the bleaching gel in the bleaching trays during 6-8 hours

Locations

Country Name City State
Spain School of Medicine and Dentistry Santiago De Compostela A Coruña

Sponsors (1)

Lead Sponsor Collaborator
University of Santiago de Compostela

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Questionnaire of dental sensitivity Patients should answer a dental sensitivity questionnaire. A a 5-point subjective numerical classification scale will be used (0=no sensitivity, 1=light, 2=mild, 3=considerable and 4=severe). Patients will a score of 0 during the treatment will be defined as patients with no sensitivity. The individual highest recorded score will be the grade of intensity for each patient. Daily, during 3 weeks
Secondary Shade evaluation with a dental spectrophotometer The color will be measured with a dental spectrophotometer and the parameters L (Lightness), C (Chroma) and H (Hue) will be recorded. To determine the color change between visits the CIEDE2000 formula will be used. Once a week, during 3 weeks
See also
  Status Clinical Trial Phase
Completed NCT06242184 - Post-operative Sensitivity in Resin Composites N/A
Recruiting NCT05298059 - The Association of CPP-ACPF Associated With LASER in the Treatment of Tooth Sensitivity After at Home Bleaching N/A
Recruiting NCT05882760 - Postoperative Sensitivity Following Placement With Different Restorative Materials In Vital Posterior Teeth Phase 4
Terminated NCT06002880 - Clinical Evaluation of OBU When Used for Indirect Dental Restorations N/A
Not yet recruiting NCT06180707 - Pregabalin Gel in Reducing Post-operative Tooth Sensitivity Surgery Caused by Bleaching With 35% Hydrogen Peroxide Phase 3
Recruiting NCT04248803 - Evaluation of Gluma Desensitizer in Post-treatment Sensitivity in Posterior Composite N/A
Recruiting NCT06273930 - Reduction of Dentine Hypersensitivity After Use of Different Dentifrices Phase 1
Completed NCT06092567 - Post-operative Sensitivity in Composite Restorations N/A
Not yet recruiting NCT05789004 - Efficacy of Tooth Bleaching With 35% and 6% Hydrogen Peroxide in Primary Dentition Phase 1/Phase 2
Recruiting NCT05923294 - Two Different Graft Harvesting Techniques Applied in Localized Gingival Recessions N/A